PAVmed Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 13.11M and sold 686.09K PAVM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 13.11M shares
Sell 686.09K shares
93% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Apr 02, 2026
Buy
Common Stock
A-Award
Lee Victoria Tou-ho
Chief Medical Officer
Officer 70 000
Value: $689.5K
Apr 02, 2026
Buy
Common Stock
A-Award
O'neil Shaun
Chief Operating Officer
C-Suite Officer 110 000
Value: $1.08M
Apr 02, 2026
Buy
Common stock
A-Award
Gordon Michael Adam
General Counsel
Officer 110 000
Value: $1.08M
Apr 02, 2026
Buy
Common stock
A-Award
Mcgrath Dennis M
President And CFO
CEO / President 180 000
Value: $1.77M
Apr 02, 2026
Buy
Common Stock
A-Award
Agrawal Sundeep
Director
Director 13 930
Value: $137.2K
Apr 02, 2026
Buy
Common stock
A-Award
Sparks Ronald M
Director
Director 13 930
Value: $137.2K
Apr 02, 2026
Buy
Common Stock
A-Award
White Debra
Director
Director 13 930
Value: $137.2K
Apr 02, 2026
Buy
Common stock
A-Award
Baxter Timothy E
Director
Director 13 930
Value: $137.2K
Apr 02, 2026
Buy
Common stock
A-Award
Glennon Michael J
Director
Director 13 930
Value: $137.2K
Apr 02, 2026
Buy
Common Stock
A-Award
Aklog Lishan
Chairman And CEO
CEO / President 350 000
Value: $3.45M
Mar 27, 2026
Buy
Common Stock
Tasso Partners, Llc
10 Percent Owner
10% Owner 0
Value: $0
Mar 24, 2026
Buy
Common Stock
Lee Victoria Tou-ho
Chief Medical Officer
Officer 0
Value: $0
Feb 03, 2026
Buy
Warrants
Tasso Partners, Llc
10 Percent Owner
10% Owner 5 365
Value: $5.37M
Sep 30, 2025
Buy
Common stock
A-Award
Sparks Ronald M
Director
Director 150 000
Value: $64.7K
Sep 30, 2025
Buy
Common stock
A-Award
White Debra
Director
Director 150 000
Value: $64.7K
Sep 30, 2025
Buy
Common stock
A-Award
Baxter Timothy E
Director
Director 150 000
Value: $64.7K
Sep 30, 2025
Buy
Common stock
A-Award
Glennon Michael J
Director
Director 150 000
Value: $64.7K
Sep 30, 2025
Buy
Common Stock
A-Award
Agrawal Sundeep
Director
Director 150 000
Value: $64.7K
Sep 30, 2025
Buy
Common Stock
A-Award
Gordon Michael Adam
General Counsel
Officer 150 000
Value: $64.7K
Sep 30, 2025
Buy
Common Stock
A-Award
Mcgrath Dennis M
President And CFO
CEO / President 150 000
Value: $64.7K
Sep 30, 2025
Buy
Common Stock
A-Award
Aklog Lishan
Chairman And CEO
CEO / President 150 000
Value: $64.7K
Sep 30, 2025
Buy
Common Stock
A-Award
O'neil Shaun
Chief Operating Officer
C-Suite Officer 150 000
Value: $64.7K
Sep 30, 2025
Buy
Common Stock
A-Award
O'neil Shaun
Chief Operating Officer
C-Suite Officer 150 000
Value: $64.7K
Sep 30, 2025
Buy
Common Stock
A-Award
Aklog Lishan
Chairman And CEO
CEO / President 150 000
Value: $64.7K
Sep 30, 2025
Buy
Common Stock
A-Award
Mcgrath Dennis M
President And CFO
CEO / President 150 000
Value: $64.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PAVMED INC
PAVmed
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE